Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota
- PMID: 29124070
- PMCID: PMC5662815
- DOI: 10.1155/2017/8102589
Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota
Abstract
Exclusive enteral nutrition (EEN) has been proven to be effective and safe in treating pediatric Crohn's disease (CD). EEN induces pediatric CD remission possibly through three pathways: (1) direct anti-inflammatory effects, (2) improved epithelial barrier function, and (3) modulation of the gut microbiota. Recent studies have demonstrated that modulation of the gut microbiota plays a major role in EEN-induced remission. Variations of microbial components, which directly influence the diversity and metabolic functions of the gut microbiota, are closely associated with the immunological conditions of the gut and the susceptibility to diseases. The reduction of proinflammatory microbial components and harmful microbial metabolites after EEN treatment greatly decreases the inflammatory injuries of the gut.
Similar articles
-
The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review.Nutrients. 2017 May 1;9(5):447. doi: 10.3390/nu9050447. Nutrients. 2017. PMID: 28468301 Free PMC article. Review.
-
Enteral Nutrition in the Management of Pediatric and Adult Crohn's Disease.Nutrients. 2018 Apr 26;10(5):537. doi: 10.3390/nu10050537. Nutrients. 2018. PMID: 29701656 Free PMC article. Review.
-
Exclusive enteral nutrition for inducing remission in inflammatory bowel disease in paediatric patients.Curr Opin Clin Nutr Metab Care. 2017 Sep;20(5):384-389. doi: 10.1097/MCO.0000000000000402. Curr Opin Clin Nutr Metab Care. 2017. PMID: 28768295 Review.
-
Exclusive enteral nutrition mediates gut microbial and metabolic changes that are associated with remission in children with Crohn's disease.Sci Rep. 2020 Nov 3;10(1):18879. doi: 10.1038/s41598-020-75306-z. Sci Rep. 2020. PMID: 33144591 Free PMC article.
-
Treatment of Active Crohn's Disease With Exclusive Enteral Nutrition Diminishes the Immunostimulatory Potential of Fecal Microbial Products.Inflamm Bowel Dis. 2024 Dec 5;30(12):2457-2466. doi: 10.1093/ibd/izae124. Inflamm Bowel Dis. 2024. PMID: 38982655 Free PMC article.
Cited by
-
Enteral nutrition protects children undergoing allogeneic hematopoietic stem cell transplantation from blood stream infections.Nutr J. 2020 Apr 10;19(1):29. doi: 10.1186/s12937-020-00537-9. Nutr J. 2020. PMID: 32276595 Free PMC article.
-
Influence of Enteral Nutrition on Gut Microbiota Composition in Patients with Crohn's Disease: A Systematic Review.Nutrients. 2020 Aug 23;12(9):2551. doi: 10.3390/nu12092551. Nutrients. 2020. PMID: 32842543 Free PMC article.
-
Epidemiological Trends of Pediatric Inflammatory Bowel Disease in Korea: A Multicenter Study of the Last 3 Years Including the COVID-19 Era.J Korean Med Sci. 2022 Sep 26;37(37):e279. doi: 10.3346/jkms.2022.37.e279. J Korean Med Sci. 2022. PMID: 36163477 Free PMC article.
-
Enteral Nutrition in Adult Crohn's Disease: Toward a Paradigm Shift.Nutrients. 2019 Sep 14;11(9):2222. doi: 10.3390/nu11092222. Nutrients. 2019. PMID: 31540038 Free PMC article. Review.
-
Gut Microbiota Composition Changes following Discontinuation of Exclusive Enteral Nutrition in Children with Crohn's Disease.Microorganisms. 2023 Feb 17;11(2):505. doi: 10.3390/microorganisms11020505. Microorganisms. 2023. PMID: 36838471 Free PMC article.
References
-
- Levine A., Turner D., Gik T. P., et al. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: Evaluation of the porto IBD group “growth relapse and outcomes with therapy” (GROWTH CD) study. Inflammatory Bowel Diseases. 2014;20(2):278–285. doi: 10.1097/01.MIB.0000437735.11953.68. - DOI - PubMed
Publication types
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical